“…In the current study, we investigated the influence of radiation-induced damage on the arrest and growth of metastatic breast cancer cells in the brain using an immune-competent mouse model of TNBC.Abbreviations used: 231BR, MDA-MB231BR human brain tropic breast cancer metastatic cell line; 3-D bSSFP, three-dimensional balanced steady-state free precession; 4T1-BR5, murine brain tropic breast cancer metastatic cell line; BBB, blood-brain barrier; bSSFP, balanced steady-state free precession; COX-2, cyclooxygenase-2; DAB, 3,3′-diaminobenzidine; DMEM, Dulbecco's modified Eagle medium; FBS, fetal bovine serum; ICAM-1, intercellular adhesion molecule-1; IgG, immunoglobulin G; IHC, immunohistochemistry; IL6, interleukin 6; IO, iron oxide nanoparticles; MHC II, major histocompatibility complex class 2; MRI, magnetic resonance imaging; PPB, Perls Prussian blue; RT, whole-brain radiotherapy; SEM, standard error of the mean; TE, echo time; TNBC, triple negative breast cancer; TNFα, tumor necrosis factor alpha; TR, repetition time To aid this investigation, we employed the use of cellular magnetic resonance imaging (MRI) techniques that enable the study of brain metastasis development longitudinally with high spatial resolution, good tumor to normal tissue contrast and single-cell sensitivity. [14][15][16][17][18][19] A key aspect of this study was our ability to use iron cell labeling and MRI to track initial cancer cell arrest, as well as tumor progression, over time. This approach could not be successfully conducted with traditional histological methods.…”